Application 050679
- Type
- NDA
- Sponsor
- HOSPIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MAXIPIME | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | Yes | Yes |
| 002 | MAXIPIME | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | Yes | Yes |
| 003 | MAXIPIME | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050679-001 | MAXIPIME | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | |
| N050679-002 | MAXIPIME | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | |
| N050679-003 | MAXIPIME | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1996-01-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050679-002 | MAXIPIME | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050679-003 | MAXIPIME | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050679-001 | MAXIPIME | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD | 1996-01-18 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050679-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050679-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050679-003 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050679-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N050679-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N050679-003 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050679-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N050679-002 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N050679-003 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N050679-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N050679-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N050679-003 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N050679-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N050679-002 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N050679-003 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N050679-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N050679-002 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N050679-003 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N050679-001 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N050679-002 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N050679-003 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N050679-001 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N050679-002 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N050679-003 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N050679-001 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N050679-002 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N050679-003 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N050679-001 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N050679-002 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N050679-003 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N050679-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N050679-002 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N050679-003 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N050679-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N050679-002 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N050679-003 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N050679-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N050679-002 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N050679-003 | AP | 1 | ea99ee380514… |
| 2023-12-20 04:57 UTC | 2023-12 | N050679-001 | AP | 1 | ea1830bbd6c7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CEFEPIME HYDROCHLORIDE AND DEXTROSE | CEFEPIME HYDROCHLORIDE | B. Braun Medical Inc. | 57517a0e-ec1b-4605-a7cc-7e3801158ec9 | 2026-04-07 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
| Cefepime Hydrochloride | CEFEPIME HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | b9914e7e-13f6-42d4-9cbb-8c7ed1ce7a01 | 2025-10-14 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
| Cefepime Hydrochloride | CEFEPIME HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | f64c181e-28c5-48ab-aa67-5ca0e3fd079c | 2025-06-30 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
| Cefepime | CEFEPIME HYDROCHLORIDE | Qilu Pharmaceutical Co., Ltd. | 80b4c811-4a71-47fb-8565-85ce9d0f782c | 2021-11-15 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
| cefepime | CEFEPIME HYDROCHLORIDE | Sagent Pharmaceuticals | de477f37-40f6-4295-ae72-a2ee36a8922e | 2021-09-29 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-0217 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0217 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0217 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0218 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0218 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0219 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0219 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0220 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0220 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0220 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68356 | SUPPL | 2021-08-12 |
| 68349 | SUPPL | 2021-08-12 |
| 48290 | SUPPL | 2017-05-09 |
| 48243 | SUPPL | 2017-05-05 |
| 39102 | SUPPL | 2016-03-03 |
| 7983 | SUPPL | 2016-03-03 |
| 30263 | SUPPL | 2014-05-06 |
| 39099 | SUPPL | 2014-05-02 |
| 39101 | SUPPL | 2013-03-19 |
| 30264 | SUPPL | 2013-03-18 |
| 18006 | SUPPL | 2012-09-11 |
| 7982 | SUPPL | 2012-09-10 |
| 7981 | SUPPL | 2009-11-20 |
| 39100 | SUPPL | 2009-09-30 |
| 44202 | ORIG | 2007-12-17 |
| 30262 | SUPPL | 2007-11-26 |
| 39098 | SUPPL | 2007-09-19 |
| 18005 | SUPPL | 2004-06-10 |
| 7980 | SUPPL | 2004-06-10 |
| 39097 | SUPPL | 2003-03-26 |
| 7979 | SUPPL | 2003-03-26 |
| 30261 | SUPPL | 2002-08-21 |
| 7978 | SUPPL | 2002-08-21 |
| 7977 | SUPPL | 2002-08-21 |
| 42673 | SUPPL | 2001-07-18 |
| 39096 | SUPPL | 1999-01-27 |
| 7976 | SUPPL | 1999-01-27 |
| 22181 | SUPPL | 1997-05-16 |
| 57440 | ORIG | 1996-01-18 |